Genetic testing :
Preimplantation Genetic Testing is a reproductive technology used along with an IVF cycle to increase the potential for a successful pregnancy and delivery of a healthy child.
PGT is a genetic test on cells extracted from 5-6 days old embryos ( called blastocyst stage ), to help select the best embryo(s) in order to achieve a higher pregnancy rate, reduce the miscarriage rate, and also to avoid a genetic disease in the baby if either one or both parents are known to be a carrier of a specific genetic disease.
- PGT-A ( A=aneuploidy ) screens for all the 46 chromosomes in the embryo for any abnormalities in their numbers e.g Down’s Syndrome with additional Chromosome 21 or Turner’s Syndrome with absent chromosome X.
- PG-M ( M= Monogenic, previously known as PGD ) is to detect a specific disease in the embryo when there is a 25% – 50% chance to have a child affected with a specific genetic disease e.g Thalassemia.
PGT-M can identify which embryo(s)are affected, unaffected, or a carrier (if applicable) for that disease before we transfer the embryo into the uterus for pregnancy.
- PGT-SR( SR = Structural rearrangement ) can identify which embryos have a normal amount of chromosomal material in cases such as translocation or deletion of a segment of chromosome which can result in unbalanced amount of genetic material resulting in recurrent miscarriages.
PGT-A requires biopsying a few cells from the trophectoderm of embryo, which requires specialized skills and suffers from false positives and negatives because chromosome numbers in the trophectoderm ( the future fetal placenta ) and the inner cell mass ( the future fetus ) are not always the same.
The use of niPGT-A (non-invasive PGT-A ), Ever Link Fertility Centre offers a solution to these problems.
Ever Link Fertility Centre is one of the first clinics in Asia to provide NICS-A, which is a non-invasive technology of genetic testing without removing any cells from the embryo, hence minimising any possible damage to the embryo.